WellsPharmtech Co., Ltd. (South Korea)
Gluthaone
Brand
WellsPharmtech Co., Ltd. (South Korea)
Category
IV Therapy
Origin
Korea
Options
1200 mg
Available options
Interested in ordering Gluthaone? Send an enquiry and our team will follow up with availability and pricing.
Overview
Gluthaone (marketed as Glutaone Inj. 1200 mg) is a high-dose reduced glutathione injectable supplied as a sterile lyophilised powder, 1200 mg per vial, 10 vials per box. It is used in clinician-led antioxidant and skin-brightening infusion programs administered intravenously or intramuscularly. Penmix Co., Ltd. is also cited in trade listings as a manufacturing source.
How it works
Delivers reduced glutathione, the body's master intracellular antioxidant, which neutralises reactive oxygen species and supports hepatic phase II detoxification. Its brightening effect is attributed to tyrosinase inhibition and a shift of melanogenesis toward lighter pheomelanin, reducing melanin pigment. The 1200 mg strength targets higher-intensity antioxidant/brightening protocols where clinically appropriate.
Indications
- Skin brightening and correction of dull, uneven tone
- Antioxidant / oxidative-stress support
- Higher-intensity hyperpigmentation protocols
- Wellness and detoxification support programs
- Combination antioxidant brightening infusions
Key features
- High-dose 1200 mg reduced-glutathione vial
- Sterile lyophilised powder for point-of-use reconstitution
- IV drip, slow IV push or IM administration
- 10-vial box suited to full treatment courses
- Positioned for higher-intensity brightening / antioxidant protocols
Benefits
- Double-strength option for advanced brightening courses
- Parenteral route bypasses poor oral glutathione absorption
- Supports intensified antioxidant and complexion protocols
- Course-based packaging aligns with 10-session programs
- Combines with vitamin C and alpha-lipoic acid cocktail menus
Composition
Reduced glutathione (GSH) 1200 mg per vial; sterile lyophilised powder reconstituted immediately before administration.
Usage & handling
Prescription injectable to be reconstituted and administered by qualified medical staff via slow IV push, IV drip or IM injection; not for self-administration. Screen for G6PD deficiency before high-dose glutathione owing to haemolysis risk, and take a full history (pregnancy/lactation, asthma, renal disease, prior reactions). Inspect the reconstituted solution, use promptly, and observe for hypersensitivity; escalate strength and course length by clinician judgement.
For medical professionals. Product information is for reference and does not replace the manufacturer's instructions for use. Availability and regulatory status vary by region.